Moderna, now wrapped on phase 3 enrollment, touts diversity of vaccine trial participants

Testing the vaccine candidate against placebo, the trial includes thousands of people from communities of color and thousands at higher risk of severe coronavirus.

Moderna and its contract research partner PPD enrolled more than 7,000 Americans over 65, plus more than 5,000 who are under 65 but have conditions such as diabetes or severe obesity. The high-risk groups make up 42% of the trial, the company said Thursday.